Deep Track Capital, LP 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 08:24 am Purchase | 2026-06-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Deep Track Capital, LP | 3,610,000 6.870% | 554,973 (+18.17%) | Filing |
| 2026-05-29 4:37 pm Purchase | 2026-05-22 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Deep Track Capital, LP | 3,055,027 5.810% | 3,055,027 (New Position) | Filing |
| 2025-11-14 08:09 am Sale | 2025-09-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Deep Track Capital, LP | 0 0.000% | -114,775 (Position Closed) | Filing |
| 2024-04-05 4:00 pm Purchase | 2024-03-27 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Deep Track Capital, LP | 114,775 9.990% | 114,775 (New Position) | Filing |